Anabolic Androgenic Steroids: Emerging Use Disorder, Mechanisms of Action, and Clinical Considerations for Pharmacotherapy
Focus · 2026-04 · 24 (2) · 168-178
DOI: 10.1176/appi.focus.20250045 ↗Kurz gefasst
Fachartikel in der Zeitschrift Focus, 2026-04. Verfasst von Eric Kutscher und 2 weiteren Autor:innen. Beteiligte Einrichtung: Divison of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Divison of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York.
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York.
- Department of Environmental Medicine, Icahn School of Medicine at Mount Sinai, New York.
ORCID-Profile: Eric Kutscher, Elena Silverman, Keren Bachi
Förderung
- NIMH NIH HHS
Zitieren
APA
Kutscher, E., Silverman, E., & Bachi, K. (2026). Anabolic Androgenic Steroids: Emerging Use Disorder, Mechanisms of Action, and Clinical Considerations for Pharmacotherapy. Focus, 24(2), 168-178. https://doi.org/10.1176/appi.focus.20250045
Vancouver
Kutscher E, Silverman E, Bachi K. Anabolic Androgenic Steroids: Emerging Use Disorder, Mechanisms of Action, and Clinical Considerations for Pharmacotherapy. Focus. 2026;24(2):168-178. doi:10.1176/appi.focus.20250045
BibTeX
@article{Kutscher2026,
author = {Kutscher, Eric and Silverman, Elena and Bachi, Keren},
title = {Anabolic Androgenic Steroids: Emerging Use Disorder, Mechanisms of Action, and Clinical Considerations for Pharmacotherapy},
journal = {Focus},
year = {2026},
volume = {24},
number = {2},
pages = {168--178},
doi = {10.1176/appi.focus.20250045}
}
EUVIMED